These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22628617)

  • 1. Tsc2, a positional candidate gene underlying a quantitative trait locus for hepatic steatosis.
    Wang CY; Stapleton DS; Schueler KL; Rabaglia ME; Oler AT; Keller MP; Kendziorski CM; Broman KW; Yandell BS; Schadt EE; Attie AD
    J Lipid Res; 2012 Aug; 53(8):1493-501. PubMed ID: 22628617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
    Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.
    Yuan M; Pino E; Wu L; Kacergis M; Soukas AA
    J Biol Chem; 2012 Aug; 287(35):29579-88. PubMed ID: 22773877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positional cloning of a type 2 diabetes quantitative trait locus; tomosyn-2, a negative regulator of insulin secretion.
    Bhatnagar S; Oler AT; Rabaglia ME; Stapleton DS; Schueler KL; Truchan NA; Worzella SL; Stoehr JP; Clee SM; Yandell BS; Keller MP; Thurmond DC; Attie AD
    PLoS Genet; 2011 Oct; 7(10):e1002323. PubMed ID: 21998599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis.
    Rhee SD; Kim CH; Park JS; Jung WH; Park SB; Kim HY; Bae GH; Kim TJ; Kim KY
    Eur J Pharmacol; 2012 Sep; 691(1-3):9-18. PubMed ID: 22742899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis.
    Massart J; Robin MA; Noury F; Fautrel A; Lettéron P; Bado A; Eliat PA; Fromenty B
    Br J Pharmacol; 2012 Mar; 165(5):1361-74. PubMed ID: 21740407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation.
    Kenerson HL; Yeh MM; Yeung RS
    PLoS One; 2011 Mar; 6(3):e18075. PubMed ID: 21479224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of mutated Srebf1 as a QTL influencing risk for hepatic steatosis in the spontaneously hypertensive rat.
    Pravenec M; Kazdova L; Landa V; Zidek V; Mlejnek P; Simakova M; Jansa P; Forejt J; Kren V; Krenova D; Qi N; Wang JM; Chan D; Aitman TJ; Kurtz TW
    Hypertension; 2008 Jan; 51(1):148-53. PubMed ID: 18071061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms.
    Bitter A; Rümmele P; Klein K; Kandel BA; Rieger JK; Nüssler AK; Zanger UM; Trauner M; Schwab M; Burk O
    Arch Toxicol; 2015 Nov; 89(11):2089-103. PubMed ID: 25182422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5'-Monophosphate (AMP)-activated Protein Kinase α1.
    Meng X; Guo J; Fang W; Dou L; Li M; Huang X; Zhou S; Man Y; Tang W; Yu L; Li J
    J Biol Chem; 2016 May; 291(20):10625-34. PubMed ID: 27013659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt.
    Kenerson HL; Subramanian S; McIntyre R; Kazami M; Yeung RS
    PLoS One; 2015; 10(2):e0117000. PubMed ID: 25646773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression.
    Haas JT; Miao J; Chanda D; Wang Y; Zhao E; Haas ME; Hirschey M; Vaitheesvaran B; Farese RV; Kurland IJ; Graham M; Crooke R; Foufelle F; Biddinger SB
    Cell Metab; 2012 Jun; 15(6):873-84. PubMed ID: 22682225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N
    Zhou B; Liu C; Xu L; Yuan Y; Zhao J; Zhao W; Chen Y; Qiu J; Meng M; Zheng Y; Wang D; Gao X; Li X; Zhao Q; Wei X; Wu D; Zhang H; Hu C; Zhuo X; Zheng M; Wang H; Lu Y; Ma X
    Hepatology; 2021 Jan; 73(1):91-103. PubMed ID: 32150756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin-insensitive up-regulation of MMP2 and other genes in tuberous sclerosis complex 2-deficient lymphangioleiomyomatosis-like cells.
    Lee PS; Tsang SW; Moses MA; Trayes-Gibson Z; Hsiao LL; Jensen R; Squillace R; Kwiatkowski DJ
    Am J Respir Cell Mol Biol; 2010 Feb; 42(2):227-34. PubMed ID: 19395678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c.
    Wang L; Zhu X; Sun X; Yang X; Chang X; Xia M; Lu Y; Xia P; Yan H; Bian H; Gao X
    Lipids Health Dis; 2019 Nov; 18(1):197. PubMed ID: 31729980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
    Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M
    Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.